
Acquisition - January 8, 2016
Sobi gains commercial rights from Pharma Swiss
Swedish Orphan Biovitrum AB has gained commercial rights from the Swiss based company PharmaSwiss SA, to distribute Relistor®, Deflux® and Solesta® in a territory including Western Europe, Czech Republic, Slovakia, Hungary and also for Relistor in Russia. “I am delighted that we have expanded our successful partnership with PharmaSwiss and provide patients and physicians with […]